Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis in Kidney Transplantation

Due to complex comorbidity, high infectious complication rates, an elevated risk of relapsing for primary renal disease, as well as inferior recipient and allograft survivals, individuals with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAVs) are often considered as poor trans...

Full description

Bibliographic Details
Main Authors: Valentina Binda, Evaldo Favi, Marta Calatroni, Gabriella Moroni
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Medicina
Subjects:
Online Access:https://www.mdpi.com/1648-9144/57/12/1325
_version_ 1827671232044072960
author Valentina Binda
Evaldo Favi
Marta Calatroni
Gabriella Moroni
author_facet Valentina Binda
Evaldo Favi
Marta Calatroni
Gabriella Moroni
author_sort Valentina Binda
collection DOAJ
description Due to complex comorbidity, high infectious complication rates, an elevated risk of relapsing for primary renal disease, as well as inferior recipient and allograft survivals, individuals with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAVs) are often considered as poor transplant candidates. Although several aspects of recurrent and de novo AAVs remain unclear, recent evidence suggests that kidney transplantation (KT) represents the best option, which is also the case for this particular subgroup of patients. Special counselling and individualized approaches are strongly recommended at the time of enlistment and during the entire post-transplant follow-up. Current strategies include avoiding transplantation within one year of complete clinical remission and thoroughly assessing the recipient for early signs of renal or systemic vasculitis. The main clinical manifestations of allograft AAV are impaired kidney function, proteinuria, and hematuria with ANCA positivity in most cases. Mixed results have been obtained using high-dose steroids, mycophenolate mofetil, or cyclophosphamide. The aim of the present review was to summarize the available literature on AAVs in KT, particularly focusing on de novo pauci-immune glomerulonephritis.
first_indexed 2024-03-10T03:37:13Z
format Article
id doaj.art-759e705e853143ffab4abe5ebe54c881
institution Directory Open Access Journal
issn 1010-660X
1648-9144
language English
last_indexed 2024-03-10T03:37:13Z
publishDate 2021-12-01
publisher MDPI AG
record_format Article
series Medicina
spelling doaj.art-759e705e853143ffab4abe5ebe54c8812023-11-23T09:28:24ZengMDPI AGMedicina1010-660X1648-91442021-12-015712132510.3390/medicina57121325Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis in Kidney TransplantationValentina Binda0Evaldo Favi1Marta Calatroni2Gabriella Moroni3Nephrology, Dialysis and Transplantation, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, 20122 Milan, ItalyKidney Transplantation, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, 20122 Milan, ItalyDepartment of Biomedical Sciences, Humanitas University, 20089 Rozzano, ItalyDepartment of Biomedical Sciences, Humanitas University, 20089 Rozzano, ItalyDue to complex comorbidity, high infectious complication rates, an elevated risk of relapsing for primary renal disease, as well as inferior recipient and allograft survivals, individuals with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAVs) are often considered as poor transplant candidates. Although several aspects of recurrent and de novo AAVs remain unclear, recent evidence suggests that kidney transplantation (KT) represents the best option, which is also the case for this particular subgroup of patients. Special counselling and individualized approaches are strongly recommended at the time of enlistment and during the entire post-transplant follow-up. Current strategies include avoiding transplantation within one year of complete clinical remission and thoroughly assessing the recipient for early signs of renal or systemic vasculitis. The main clinical manifestations of allograft AAV are impaired kidney function, proteinuria, and hematuria with ANCA positivity in most cases. Mixed results have been obtained using high-dose steroids, mycophenolate mofetil, or cyclophosphamide. The aim of the present review was to summarize the available literature on AAVs in KT, particularly focusing on de novo pauci-immune glomerulonephritis.https://www.mdpi.com/1648-9144/57/12/1325chronic kidney diseasekidney transplantANCA-associated vasculitispauci-immune glomerulonephritispatient survivalgraft survival
spellingShingle Valentina Binda
Evaldo Favi
Marta Calatroni
Gabriella Moroni
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis in Kidney Transplantation
Medicina
chronic kidney disease
kidney transplant
ANCA-associated vasculitis
pauci-immune glomerulonephritis
patient survival
graft survival
title Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis in Kidney Transplantation
title_full Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis in Kidney Transplantation
title_fullStr Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis in Kidney Transplantation
title_full_unstemmed Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis in Kidney Transplantation
title_short Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis in Kidney Transplantation
title_sort anti neutrophil cytoplasmic antibody associated vasculitis in kidney transplantation
topic chronic kidney disease
kidney transplant
ANCA-associated vasculitis
pauci-immune glomerulonephritis
patient survival
graft survival
url https://www.mdpi.com/1648-9144/57/12/1325
work_keys_str_mv AT valentinabinda antineutrophilcytoplasmicantibodyassociatedvasculitisinkidneytransplantation
AT evaldofavi antineutrophilcytoplasmicantibodyassociatedvasculitisinkidneytransplantation
AT martacalatroni antineutrophilcytoplasmicantibodyassociatedvasculitisinkidneytransplantation
AT gabriellamoroni antineutrophilcytoplasmicantibodyassociatedvasculitisinkidneytransplantation